Herbas VPB

Print
EN | LT
LT - Išsėtinės sklerozės gydymas lakvinimodu
EN - TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61P 25/00 (2006.01)
A01N 43/42 (2006.01)
A61K 31/4704 (2006.01)
A61K 31/136 (2006.01)
A61K 38/16 (2006.01)
A61K 45/06 (2006.01)
European patent
(11) Number of the document 2442651
(13) Kind of document T
(96) European patent application number 10789873.6
Date of filing the European patent application 2010-06-18
(97) Date of publication of the European application 2012-04-25
(45) Date of publication and mention of the grant of the patent 2015-07-29
(46) Date of publication of the claims translation 2015-11-25
PCT application
(86) Number PCT/US2010/001759
Date 2010-06-18
PCT application publication
(87) Number WO 2010/147665
Date 2010-12-23
Priority applications
(30) Number Date Country code
269070 P 2009-06-19 US
Inventors
(72)
TARCIC, Nora, IL
BAR-ZOHAR, Dan, IL
KOFLER, Dina, IL
Grantee
(73) Teva Pharmaceutical Industries Ltd., 5 Basel Street P.O. Box 3190, 49131 Petah Tiqva, IL
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Išsėtinės sklerozės gydymas lakvinimodu
  TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD
Last renewal fee
Payment date Validity (years) Amount
2017-05-29 8 185.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2018-06-18